坂東 裕子
,
Norikazu Masuda
,
Shoichiro Ohtani
,
Toshimi Takano
,
Kenichi Inoue
,
Eiji Suzuki
,
Rikiya Nakamura
,
Hiroko BANDO
,
Yoshinori Ito
,
Kazushige Ishida
,
Takashi Yamanaka
,
Katsumasa Kuroi
,
Hiroyuki Yasojima
,
Hiroi Kasai
,
Tsuyoshi Takasuka
,
Takaki Sakurai
,
Tatsuki R. Kataoka
,
Satoshi Morita
,
Shinji Ohno
,
Masakazu Toi
… group A), TCbHP (4 cycles) followed by trastuzumab emtansine + pertuzumab (T-DM1+P; … group B), and T-DM1+P (4 cycles; … group C) regimens in HER2‐positive primary breast cancer patients; … concurrent hormone therapy with T-DM1+P was administered in case of estrogen receptor positivity (ER+). …
IR